Boronated nucleoside, nucleotide and oligonucleotide compounds, compositions and methods for using same
US5130302A · kind A · utility
506Cited by
0References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 20, 1989 |
| Grant date | Jul 14, 1992 |
| Priority date | — |
| Expiry date | Dec 20, 2009 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H23/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
A novel class of pharmaceutically active boronated nucleosides are provided. The nucleosides are boronated at a ring nitrogen of the purine or pyrimidine or analogues thereof. Also provided are phosphate esters of these nucleosides and oligomers thereof. Methods of making and using the boronated nucleosides are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.